Vistagen Therapeutics Cash from Financing (TTM) Insights

Vistagen Therapeutics Inc (VTGN)

4.62 -0.10 (-2.12%) USD | NASDAQ | Apr 25, 09:57

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2008. Upgrade now.

Date	Value
December 31, 2023	128.17M
September 30, 2023	34.35M
June 30, 2023	-0.1612M
March 31, 2023	-1.042M
December 31, 2022	-0.6199M
September 30, 2022	1.803M
June 30, 2022	9.487M
March 31, 2022	10.48M
December 31, 2021	14.54M
September 30, 2021	106.50M
June 30, 2021	112.10M
March 31, 2021	114.10M
December 31, 2020	112.89M
September 30, 2020	20.09M
June 30, 2020	7.051M
March 31, 2020	4.012M
December 31, 2019	11.52M
September 30, 2019	12.61M
June 30, 2019	17.36M
March 31, 2019	17.42M
December 31, 2018	6.997M
September 30, 2018	18.35M
June 30, 2018	15.70M
March 31, 2018	16.52M
December 31, 2017	16.64M

Date	Value
September 30, 2017	3.139M
June 30, 2017	1.091M
March 31, 2017	9.994M
December 31, 2016	10.52M
September 30, 2016	11.95M
June 30, 2016	14.06M
March 31, 2016	5.193M
December 31, 2015	5.543M
September 30, 2015	4.259M
June 30, 2015	2.301M
March 31, 2015	2.839M
December 31, 2014	2.334M
September 30, 2014	2.312M
June 30, 2014	2.717M
March 31, 2014	1.498M
December 31, 2013	2.639M
September 30, 2013	3.411M
June 30, 2013	4.102M
March 31, 2013	4.156M
December 31, 2012	3.220M
September 30, 2012	3.251M
June 30, 2012	1.898M
March 31, 2012	3.540M
December 31, 2011	2.894M
September 30, 2011	1.759M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.042M

Minimum

Mar 2023

128.17M

Maximum

Dec 2023

37.64M

Average

12.61M

Median

Sep 2019

Cash from Financing (TTM) Benchmarks